Tuesday’s Midday Stock Update: Sears Holdings (SHLD), Amedica (AMDA), Antares Pharma (ATRS), Sangamo Biosciences (SGMO), Clean Diesel Technologies (CDTI)

By Carrie Williams

So far Tuesday, March 27, NASDAQ is down -2.99% and the S&P is down -0.1%. Here are this morning’s most active stocks: Sears Holdings (NASDAQ:SHLD), Amedica (NASDAQ:AMDA), Antares Pharma (NASDAQ:ATRS), Sangamo Biosciences (NASDAQ:SGMO) and Clean Diesel Technologies (NASDAQ:CDTI).

Sears Holdings is up 12.61% in midday trading to $2.59. Shares opened today at $2.30. The company has a 52-week low of $1.99 and a 52-week high of $14.32. On the Street’s front, the average 12-month analyst price target for the stock is $2.00, marking a -13.04% potential downside from current levels. In a report issued on February 16, Susquehanna analyst Bill Dreher reiterated a Sell rating on SHLD, with a price target of $2, which represents a potential downside of 13% from where the stock is currently trading.

Amedica is down -11.03% in midday trading to $1.52. Shares opened today at $1.71. The company has a 52-week low of $1.37 and a 52-week high of $6.93.

Antares Pharma is down -10.93% in midday trading to $2.20. Shares opened today at $2.47. The company has a 52-week low of $1.58 and a 52-week high of $4.09. On the Street’s front, the average 12-month analyst price target for the stock is $3.50, marking a 41.70% potential upside from current levels. In a report released today, H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on ATRS, with a price target of $3.50, which implies an upside of 42% from current levels. In the last 30 days, insiders have sold $81.4K worth of ATRS shares.

Sangamo Biosciences is down -9.91% in midday trading to $20.45. Shares opened today at $22.70. The company has a 52-week low of $4.05 and a 52-week high of $27.50. On the Street’s front, the average 12-month analyst price target for the stock is $28.40, marking a 25.11% potential upside from current levels. In a report issued on March 13, Wedbush analyst Liana Moussatos reiterated a Hold rating on SGMO, with a price target of $8, which implies a downside of 65% from current levels. Separately, on February 23, Cowen’s Ritu Baral maintained a Buy rating on the stock . In the last 30 days, insiders have sold $235K worth of SGMO shares. Over the last 3 months, the insider sentiment on Sangamo Biosciences has been negative based on 26 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Clean Diesel Technologies is down -9.74% in midday trading to $1.02. Shares opened today at $1.13. The company has a 52-week low of $0.97 and a 52-week high of $3.72.